chr4-54733155-A-G
Variant summary
The NM_000222.3(KIT):c.2447A>G (p.Asp816Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 9.22). Variant has been reported in ClinVar as Uncertain Significance (★). A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.D816H: Pathogenic (ClinVar VariationId 13863, 2 stars) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.D816= (synonymous): Conflicting_classifications_of_pathogenicity (ClinVar VariationId 286360); p.D816Y: Uncertain_significance (ClinVar VariationId 13860, 1 star) This exact variant is established as oncogenic in: CGI (Cancer Genome Interpreter). The variant position is a cancer hotspot (cancerhotspots.org) with 88 samples affected at this amino acid position. This exact variant is curated in the UniProt human variants database as Uncertain Significance.
Frequency
Consequence
NM_000222.3 missense
Scores
Clinical Significance
Conservation
Publications
- gastrointestinal stromal tumorInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
- piebaldismInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P, Ambry Genetics
- cutaneous mastocytosisInheritance: AD Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
- mastocytosisInheritance: AD Classification: STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Likely_pathogenic. The variant received 8 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PM1Mutational hot spot or critical domain | Missense neighbourhood hotspot (≥2 P/LP within ±8 AA, OR ≥ 5 vs. background) — PM1; In-domain: 0 pathogenic, 0 benign rare missense variants.; ±8 AA neighbourhood: 6 pathogenic, 0 benign (OR vs. background: 65.0). | ||
| PM2Absent/extremely low in population databases | Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD/XL) (threshold 0.0001) — PM2 moderate. | ||
| PM5Novel missense at known pathogenic residue | Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.D816H: Pathogenic (ClinVar VariationId 13863, 2 stars); Other variants at the same amino acid residue (not pathogenic): p.D816= (synonymous): Conflicting_classifications_of_pathogenicity (ClinVar VariationId 286360); p.D816Y: Uncertain_significance (ClinVar VariationId 13860, 1 star) | ||
| PP3Computational evidence supports damaging effect | Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — moderate evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Moderate). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000222.3. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
KIT | MANE Select | c.2447A>G p.Asp816Gly | missense | Exon 17 of 21 | Prot: NP_000213.1 UniProt: | |
KIT | c.2450A>G p.Asp817Gly | missense | Exon 17 of 21 | Prot: NP_001372213.1 UniProt: | ||
KIT | c.2447A>G p.Asp816Gly | missense | Exon 17 of 21 | Prot: NP_001372219.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
KIT | TSL:1MANE Select | c.2447A>G p.Asp816Gly | missense | Exon 17 of 21 | Prot: ENSP00000288135.6 UniProt: | |
KIT | TSL:1 | c.2435A>G p.Asp812Gly | missense | Exon 17 of 21 | Prot: ENSP00000390987.3 UniProt: | |
KIT | c.2450A>G p.Asp817Gly | missense | Exon 17 of 21 | Prot: ENSP00000509371.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 3 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 exome | Cov:30 | ||||
GnomAD4 genome | Cov:32 | ||||
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 32 | |
AlphaMissense | Pathogenic | 1.0 | |
BayesDel_addAF | Pathogenic | 0.40 | D |
BayesDel_noAF | Pathogenic | 0.33 | |
CADD | Pathogenic | 30 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Pathogenic | 0.83 | D |
Eigen | Uncertain | 0.61 | |
Eigen_PC | Pathogenic | 0.67 | |
FATHMM_MKL | Pathogenic | 0.99 | D |
FuncVEP CTI | Pathogenic | 0.91 | |
GPN-Star LLR | N/A | -9.1 | |
GPN-Star score | N/A | 9.1 | |
LIST_S2 | Uncertain | 0.89 | D |
M_CAP | Uncertain | 0.16 | D |
MetaRNN | Pathogenic | 0.95 | D |
MetaSVM | Uncertain | 0.31 | D |
Mutation Taster | N/A | 0/100 | disease causing |
MutationAssessor | Benign | 0.83 | L |
PhyloP100 | Pathogenic | 9.2 | |
popEVE | Uncertain | -4.8 | |
PrimateAI | Pathogenic | 0.83 | D |
PROVEAN | Pathogenic | -5.9 | D |
REVEL | Pathogenic | 0.93 | |
Sift | Uncertain | 0.012 | D |
Sift4G | Uncertain | 0.010 | D |
Varity_R | N/A | 0.89 | |
VESM-3B | Benign | -12 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.